Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 1998

View Archived Issues

Trimeris reports anti-HIV drug with a novel mechanism of action

Company Profile: Ventana Genetics

OCT: suppression of PTH secretion in mouse model of severe parathyroid hyperplasia

Neuroprotective effects demonstrated for novel sigma1-receptor agonist

Cyclic amines active against H. pylori in development at Takeda

Phosphodiesterase inhibitors with antiasthmatic efficacy

AIDS patients not taking their medications, new study shows

Anticancer activity of mEGP has been reported

Favorable results obtained in SomatoKine burn study

Nexell initiates phase I/II clinical trial of genetically corrected CD34 cells

PDE IV inhibitors focus of attention at recent respiratory care congress

Ribozyme's anticancer drug Angiozyme shows promise in preclinical trials

Genset announces discovery of novel prostate cancer-related gene

ArQule and Beth Israel enter collaboration for osteopenic disease drug discovery

Agouron's MMP inhibitor AG-3340 enters phase II/III trials

YF-476, a potent gastrin/CCK-B antagonist with gastric antisecretory activity

Wyeth-Ayerst has option to license Teikoku Hormone's antiandrogen

Spotlight on NK antagonists for asthma

Epix Medical: Q1 1998 highlights

Antiallergic/antiinflammatory effects of heparin and heparin fractions under evaluation

ImmunoGen: Q3 1998 and nine-month highlights

Oxigene: Q1 1998 highlights

Nikken initiates development of new anticancer agent

New direction taken in Toray's analgesic drugs program

BioChem Pharma initiates clinical testing of another AIDS drug

Bayer fluoroquinoline is effective against murine tuberculosis

FDA advisory committee requests additional information on Cryptaz

NCX-4016: a nitroderivative of aspirin with increased antiplatelet activity

FDA approves improved oral contraceptive agent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...